Publicacions
-
Alsina L, Mohr A, Montañés M, Oliver X, Martín E, Pons J, Drewe E, Papke J, Günther G, Chee R, Gompels M and investigators of the Flebogamma DIF PASS Study Group.
Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients
pharmacology research & perspectives . 5(5): . Nº de cites: 8
-
Martínez-Valdez L, Deyà-Martinez A, Giner MT, Berrueco R, Esteve-Solé A, Juan M, Plaza-Martín AM and Alsina L.
Evans Syndrome as First Manifestation of Primary Immunodeficiency in Clinical Practice
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 39(7): 490-494. Nº de cites: 13
-
Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton-Lopez J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A and Pediatric Rheumatology International Trials Organization, the Childhood Arthriti.
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
JOURNAL OF PEDIATRICS . 189: 72-30787. Nº de cites: 43
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Rodó X and Morguí JA.
Kawasaki disease is more prevalent in rural areas of Catalonia (Spain)
ANALES DE PEDIATRIA . 87(4): 226-231. Nº de cites: 4
-
Esteve-Solé A, Deyà-Martinez A, Teixido M, Ricart E, Gompertz M, Torradeflot M, de Moner N, Gonzalez EA, Plaza-Martín AM, Yagüe-Ribes J, Juan M and Alsina L.
Immunological Changes in Blood of Newborns Exposed to Anti-TNF-a during Pregnancy
FRONTIERS IN IMMUNOLOGY . 8: 1123-1123. Nº de cites: 48
-
Martorell A, Alonso E, Echeverría L, Escudero C, García-Rodríguez R, Blasco C, Bone J, Borja-Segade J, Bracamonte T, Claver A, Corzo JL, De la Hoz B, Del Olmo R, Domínguez-Sánchez O, Fuentes-Aparicio V, Guallar I, Larramona H, Martín-Muñoz F, Matheu V, Michavila A, Ojeda I, Ojeda P, Piquer-Gibert M, Poza P, Reche M, Río PRD, Rodríguez M, Ruano F, Sánchez-García S, Terrados S, Valdesoiro L, Vazquez-Ortiz M and Expert panel selected from members of the Spanish Societies of Pediatric Allergo.
Oral immunotherapy for food allergy: A Spanish guideline. Egg and milk immunotherapy Spanish guide (ITEMS GUIDE). Part 2: Maintenance phase of cow milk (CM) and egg oral immunotherapy (01T), special treatment dosing schedules. Models of dosing schedules of OIT with CM and EGG*
ALLERGOLOGIA ET IMMUNOPATHOLOGIA . 45(5): 508-518. Nº de cites: 11
-
Arostegui JI, Anton-Lopez J, Calvo I, Robles A, Iglesias-Jimenez E, López-Montesinos B, Banchereau R, Hong S, Joubert Y, Junge G, Pascual V and Yagüe J.
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
ARTHRITIS & RHEUMATOLOGY . 69(8): 1679-1688. Nº de cites: 34
-
Martorell A, Alonso E, Echeverría L, Escudero C, García-Rodríguez R, Blasco C, Bone J, Borja-Segade J, Bracamonte T, Claver A, Corzo JL, De la Hoz B, Del Olmo R, Domínguez-Sánchez O, Fuentes-Aparicio V, Guallar I, Larramona H, Martín-Muñoz F, Matheu V, Michavila A, Ojeda I, Ojeda P, Piquer-Gibert M, Poza P, Reche M, Rodríguez Del Río P, Rodríguez M, Ruano F, Sánchez-García S, Terrados S, Valdesoiro L, Vazquez-Ortiz M and Expert panel selected from members of the Spanish Societies of Pediatric Allergo.
Oral immunotherapy for food allergy: A Spanish guideline. Immunotherapy egg and milk Spanish guide (items guide). Part I: Cow milk and egg oral immunotherapy: Introduction, methodology, rationale, current state, indications contraindications and oral immunotherapy build-up phase
ALLERGOLOGIA ET IMMUNOPATHOLOGIA . 45(4): 393-404. Nº de cites: 10
-
Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton-Lopez J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, In, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P and Thomson W.
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
ANNALS OF THE RHEUMATIC DISEASES . 76(5): 906-913. Nº de cites: 105
-
Ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton-Lopez J, Barron KS, Benseler SM, Brogan PA, Cantarini L, Cattalini M, Cochino AV, De Benedetti F, Dedeoglu F, De Jesus AA, Della Casa Alberighi O, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Koné-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Ozen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Gattorno M and Frenkel J.
Development of the autoinflammatory disease damage index (ADDI)
ANNALS OF THE RHEUMATIC DISEASES . 76(5): 821-830. Nº de cites: 62